DRW Securities’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KYTX
ACM
DRW Securities's KYTX Position: Q3 2026 in Review
DRW Securities opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 19,325 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #813 among its holdings.
128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.
- DRW Securities held 19,325 shares of Kyverna Therapeutics worth $131K as of Q3 2026.
- Kyverna Therapeutics was a new DRW Securities position in Q3 2026.
- Kyverna Therapeutics made up ﹤0.01% of DRW Securities's portfolio in Q3 2026, its #813 holding.
- 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.
Based on DRW Securities's 13F filing for Q3 2026, filed 13 Nov 2026.